KRAS and cancer: Consistent with this hypothesis, our findings revealed that ALK-rearranged cancer had distinctive microRNA expression profiles, while the EGFR- and KRAS-mutated cancers had similar microRNA expression profiles, despite having several differentially expressed microRNAs.